An inhalation device, assembly or system can include a kit and a pharmaceutical composition. The device can be adapted for administering therapeutic aerosols to pediatric patients, including neonates, infants or toddlers. The device can further include a vibrating mesh aerosol generator that can be insertable into a flow channel of the inhalation device through a lateral opening, and a valved face mask. The device can be connectable to a gas source through which a gas, such as oxygen, can be received into the flow channel at a low flow rate.

Methods are provided for the treatment of RSV infections in young children. More specifically, methods are provided wherein polypeptides that bind F protein of hRSV and that neutralize RSV infection are administered to the lungs of young children at specific dose regimens.

A system for measuring the vital parameters of low care patients is described. The system includes a connecting element for a nasal cannula or breathing mask for providing a fluidic connection with the patient and a flow and/or pressure sensor in fluidic connection with the nasal cannula or breathing mask, for sensing, when the nasal cannula or breathing mask is connected to the system, at least a negative pressure signal. The system also includes a processor configured for deriving, directly based on said at least a negative pressure signal, information related to the breathing cycle, and an output means configured for outputting at least one vital parameter of the patient, the outputting comprising outputting information related to the breathing cycle.

A method of controlled delivery of breathing gases is described the method comprising: applying breathing gas pressure within the first naris of a patient during inhalation; applying breathing gas pressure within the second naris of the patient during inhalation; applying breathing gas pressure within the first naris of the patient during exhalation; and applying breathing gas pressure within the second naris of the patient during exhalation, wherein the breathing gas pressure applied to the first naris during inhalation is higher than the gas pressure applied to the second naris during inhalation and the breathing gas inflow to the patient is substantially through the first naris during inhalation and wherein the breathing gas pressure applied to the first naris during exhalation is lower than the gas pressure applied to the second naris during exhalation and the gas outflow from the patient is substantially through the first naris during exhalation. An apparatus and system implementing the method is also described.

A valve structure for treating a patient suffering from obstructive sleep apnea is provided. The valve structure is connected to an air flow generator and is connected to a mask that covers at least the nostrils of a patient. The valve structure includes an inlet pressure port attached to the air flow generator and an expiration valve that includes an expiratory membrane, a primary seat and a secondary seat. During inspiration, the expiratory membrane forms a seal with the primary seat, and during expiration, the expiratory membrane forms a seal with the secondary seat.

A respiratory flow therapy apparatus including a sensing chamber which measures a flow of gases provided to a patient. The sensing chamber can be located after a blower and/or mixer. The sensing chamber can include an ultrasonic transducer, a temperature sensor, a heated temperature sensing element, and/or a gas concentration sensor. A flow path of gases used in conjunction with the sensor system prevents unwanted vorticity in the flow of gases that can create anomalies in measuring flow.

An emergency respirator ventilator that comprising an air cylinder and piston/piston rod for compressing an air bag to transmit air to a patient, e.g., during situations where fully equipped ventilators are not immediately available.

According to one aspect, there is provided a device (4) for providing supplemental oxygen to a subject (8), the device (4) comprising a subject interface (10) through which the subject (8) can inhale; a container (12) that has a first outlet (18) connected to the subject interface (10) to allow gas with an elevated oxygen level stored in the container (12) to be inhaled by the subject (8), a first inlet (24), and a material (15) for removing a specific gas from air passing through the container (12) to increase the oxygen content of the air passing through the container (12); and an air blower (14) that is connected to the first inlet (24) of the container (12) and that is configured to supply air into the container (12) as the subject (8) uses the device (4).

A fluid delivery system provides fluid, such as supplement oxygen, to a patient in response to inhalation. The fluid delivery system includes a valve assembly that is triggered by sensing onset of inspiration by measuring a change in temperature of air flow in a nasal or oral cannula, mask or helmet.

A fluid delivery system provides fluid, such as supplement oxygen, to a patient in response to inhalation. The fluid delivery system includes a valve assembly that is triggered by sensing onset of inspiration by measuring a change in temperature or fluid flow of air flow in a nasal or oral cannula, mask or helmet.